Home

September 2023

Death after TAVR | Excessive cannabis use linked to greater risk of heart attack, other cardiovascular events (09/29/2023)

Surgeons make history | Cardiology groups push for change | Empagliflozin for CKD | More from the last week (09/29/2023)

Heart Rhythm: Beloved electrophysiologist killed in accident | FDA's recall update | EP studies during TAVR (09/29/2023)

Key takeaways from a new study on CVD, CKD & type 2 diabetes | FDA reviewing Merck's new PAH drug (09/28/2023)

World Heart Day webinar to focus on CCTA, FFR-CT | AFib recurrence after ablation | PET in long-COVID patients (09/27/2023)

Cardiac Imaging Highlights: CT on the rise | Trading kickbacks for referrals | Nuclear cardiology needs to evolve (09/27/2023)

The latest in tricuspid valve care | Bivalirudin vs. heparin | Cardiologists develop how-to guide for home-based care (09/26/2023)

Interventional Cardiology: A new device for severe TR | PCI before TAVR | Immediate vs. staged multivessel PCI (09/26/2023)

Surgeons transplant pig heart into human patient for second time | Warfarin after TAVR | AI-powered drug research (09/25/2023)

The world's 50 best heart hospitals | Doc busted for fraud | A new, independent medical board? | More from the last week (09/22/2023)

More info on cardiology's push for a new, independent medical board | PFA's potential | Empagliflozin & CKD (09/22/2023)

Economics Highlights: Cardiologist traded kickbacks for imaging referrals | M&A news | Affordable CVD meds (09/22/2023)

The world's 50 best hospitals for cardiac surgery | Cardiology groups developing a new medical board (09/21/2023)

Breaking News: Cardiology groups announce plan to develop a new, independent medical board (09/21/2023)

Cardiologist to pay $6.5M for complex fraud scheme | Martha Gulati on cardiac CT | EP studies during TAVR (09/20/2023)

Care Delivery Highlights: The world's top hospitals for cardiology | Screening for AS | Missed opportunities (09/20/2023)

The 50 best heart hospitals in the world | Previewing ASNC 2023 | Protecting the esophagus during ablation (09/19/2023)

Cannabis use may not increase heart attack risk—but questions remain | NOACs vs. VKAs in post-TAVR AFib (09/18/2023)

Heart Health Highlights: New data on semaglutide | Weight loss products recalled over possible heart damage, other risks (09/18/2023)

New heart device used for first time in US | Cardiologist headed to trial for date rape | PCI before TAVR (09/15/2023)

Cardiologist killed in accident | Medtronic faces a lawsuit | Reimbursements & coding | More from the last week (09/15/2023)

Vascular & Endovascular: Catheters recalled after 12 injuries | The first CVD drug of its kind | Statins & bleeding strokes (09/15/2023)

Low-cost generic programs offer CVD meds at affordable prices | Strain imaging making a significant impact (09/14/2023)

Reimbursements & coding in echocardiography | More M&A news out of Florida | AFib ablation & mental health (09/13/2023)

ASE 2023: Echo reinbursement | POCUS training | Creating cardio-oncology programs (09/13/2023)

How AI can make echo labs more efficient | FDA approves new-look CLTI treatment | ACC takes on LDL screening (09/12/2023)

Q&A: The potential of AS screening programs | POCUS training for noncardiologists | Cardiologist killed (09/11/2023)

Structural Heart Highlights: Interventional echocardiography | Valve-in-valve TMVR | AI spots missed defects (09/11/2023)

Medtronic faces a new lawsuit | Building a cardio-oncology program | 'Must-buy' stocks | PCI in older patients (09/08/2023)

FDA's update on troubled heart devices | Redo TAVR | The high costs of semaglutide | More from the last week (09/08/2023)

Heart Failure Highlights: Key recalls | Medicare price negotiations | Multimodality imaging & AI | Mortality rates (09/08/2023)

Multimodality imaging for heart failure | Bleeding events after TAVR | Boston Scientific's new FDA approval (09/07/2023)

Deaths from obesity-related CVD | PE-backed management group makes a move | Abbott's new acquisition (09/06/2023)

TAVR Highlights: Premounted valve saves time | Alternatives to transfemoral access | Surgeon sues hospital (09/06/2023)

High costs may limit impact of weight loss drug semaglutide | Postoperative delirium after TAVR (09/05/2023)

August's Top 10 Stories: Multiple recalls | AI-enabled echo | New TAVR valves save time | 'Unfair' policies (09/05/2023)

AI-enabled echo | Semaglutide & heart failure | Medicare price negotiations | ViV TMVR | More from the last week (09/01/2023)

FDA shares update on troubled heart devices | Redo TAVR with balloon-expandable valves is safe & effective (09/01/2023)

Design by Adaptive Theme